Anxiety disorders affect millions of Americans, creating persistent worry, fear, and physical symptoms that interfere with daily functioning. While many people find relief through traditional approaches like therapy and anti-anxiety medications, approximately 40-50% of individuals with anxiety disorders don’t achieve adequate response with conventional treatments. If you’ve tried multiple medications, worked with therapists, practiced coping strategies, and still experience significant anxiety symptoms, specialized treatment approaches may offer new possibilities for relief.
EleMental Health specializes in treatment-resistant anxiety disorders, offering evidence-based interventions that work through different mechanisms than traditional anxiolytics. Our comprehensive approach includes Ketamine-Assisted Therapy (available through three delivery methods), therapeutic support, and complementary wellness options. Many patients who haven’t responded to conventional treatments experience meaningful improvement with these specialized approaches.
Founded by Nykol Bailey Rice, CRNA and PMHNP, EleMental Health is one of Idaho’s pioneering ketamine clinics. Since our founding, we’ve served as a trusted referral center for major regional hospitals and mental health providers. Our comprehensive approach goes beyond medication alone, combining evidence-based treatments with therapeutic support to address treatment-resistant conditions.
Unlike clinics that focus solely on medication delivery, we offer multiple treatment options tailored to your specific needs. Our Ketamine-Assisted Therapy program includes three delivery methods—IV infusion, IM injection, and compounded nasal spray—each integrated within a comprehensive therapeutic framework. Our team includes nine specially-trained facilitators with credentials including Licensed Professional Counselor (LPC), Licensed Clinical Professional Counselor (LCPC), Doctor of Psychology (PsyD), Master of Arts (MA), Physician Assistant-Certified (PA-C), and Master of Science in Nursing (MSN). These facilitators provide preparation, session facilitation, and integration support throughout your treatment.
Located at 2800 W Overland Rd in Boise, we’ve built our practice on clinical expertise, patient-centered care, and a commitment to evidence-based interventions. Results vary by individual, and our comprehensive screening process ensures treatment is appropriate for your specific situation.
Anxiety is more than occasional worry or nervousness—it’s a persistent condition characterized by excessive fear, worry, and physical symptoms that interfere with daily life. Anxiety disorders represent the most common category of mental health conditions, affecting an estimated 18% of adults in the United States annually.
Generalized Anxiety Disorder (GAD): Persistent, excessive worry about various aspects of life—work, health, finances, relationships—that’s difficult to control. Physical symptoms often include restlessness, muscle tension, fatigue, difficulty concentrating, irritability, and sleep disturbances.
Social Anxiety Disorder (Social Phobia): Intense fear of social situations where you might be judged, embarrassed, or scrutinized. This can significantly limit participation in work, school, and social activities.
Panic Disorder: Recurrent unexpected panic attacks—sudden episodes of intense fear accompanied by physical symptoms like rapid heartbeat, sweating, trembling, shortness of breath, and feelings of impending doom. Many people develop fear of having future panic attacks, which can become disabling.
Specific Phobias: Intense, irrational fear of specific objects or situations that poses little actual danger but provokes significant avoidance behavior.
For many people, anxiety responds well to first-line treatments including cognitive-behavioral therapy (CBT), exposure therapy, and medications like selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These conventional approaches help millions of people manage their symptoms effectively.
However, approximately 40-50% of individuals with anxiety disorders don’t achieve adequate response with standard treatments. This is known as treatment-resistant anxiety, typically defined as inadequate response to at least two different medication trials at therapeutic doses for sufficient duration, often combined with appropriate psychotherapy. If you’ve tried multiple medications, increased dosages, added augmentation strategies, participated in therapy, and still experience significant anxiety symptoms, you may have treatment-resistant anxiety.
The burden extends beyond the anxiety symptoms themselves. Traditional anti-anxiety medications require 4-8 weeks to take full effect, meaning each new medication trial involves months of waiting and uncertainty. Benzodiazepines offer rapid relief but carry risks of dependence and don’t address underlying anxiety mechanisms. Many people cycle through treatments for years without finding adequate relief.
When conventional approaches haven’t worked, specialized interventions that work through different mechanisms offer new possibilities for symptom reduction and improved quality of life.
At EleMental Health, we specialize in treatment-resistant anxiety using interventions that work differently than conventional anxiolytics. Our primary approach involves ketamine—a medication that targets the glutamate system rather than the serotonin, norepinephrine, or GABA systems affected by traditional anti-anxiety medications.
Ketamine has been used safely as an FDA-approved anesthetic for over 50 years. In recent years, researchers have discovered that subanesthetic doses of ketamine—much lower than those used for anesthesia—produce rapid anxiolytic effects in people with treatment-resistant anxiety disorders. This discovery has expanded treatment options for individuals who haven’t found relief with conventional approaches.
While traditional anxiolytics target monoamine neurotransmitter systems or GABA receptors and typically require weeks to produce effects, ketamine acts on glutamate, the brain’s primary excitatory neurotransmitter. This different mechanism explains both the rapid onset of effects and why ketamine can help individuals who haven’t responded to traditional medications. The use of ketamine for anxiety disorders is considered “off-label”—meaning it’s used for a purpose beyond its original FDA approval—but is supported by growing research and clinical experience.
Research demonstrates that ketamine’s anxiolytic effects can emerge within 1-4 hours after administration and persist for up to one week after a single dose. With repeated dosing and maintenance therapy, many patients experience sustained improvement in anxiety symptoms. This rapid timeline represents a fundamentally different approach than traditional anxiolytics that require weeks of daily administration before effects emerge.
Ketamine’s anxiolytic mechanism involves multiple interconnected processes in the brain. At its core, ketamine acts as an N-methyl-D-aspartate (NMDA) receptor antagonist, temporarily blocking these glutamate receptors. While the exact mechanisms continue to be studied, current research suggests ketamine works through several complementary pathways relevant to anxiety reduction.
The NMDA receptor blockade affects inhibitory interneurons in the brain, leading to increased release of glutamate. This increase in glutamate activates AMPA receptors on neighboring neurons, triggering a cascade of cellular events. This cascade includes activation of signaling pathways involving brain-derived neurotrophic factor (BDNF) and mammalian target of rapamycin (mTOR), both critical for synaptic plasticity and neuronal growth.
Anxiety disorders are associated with dysfunction in fear-processing circuits, particularly involving the amygdala, prefrontal cortex, and hippocampus. Chronic anxiety can lead to maladaptive neural patterns—essentially, the brain becomes “stuck” in patterns of excessive threat detection and fear response. Ketamine appears to disrupt these maladaptive patterns by promoting neuroplasticity and facilitating what researchers call “fear extinction”—the process by which learned fear responses gradually diminish.
Research demonstrates that ketamine increases synaptic protein synthesis, promotes dendritic spine growth, and enhances connectivity in mood- and anxiety-regulating brain circuits. These neuroplastic changes happen rapidly, within hours of ketamine administration, which correlates with the rapid improvement in anxiety symptoms many patients experience. Additionally, ketamine may facilitate the consolidation of fear extinction learning, making it potentially valuable when combined with exposure-based therapies.
The speed and mechanism of ketamine’s effects have expanded our understanding of anxiety treatment. Rather than slowly adjusting neurotransmitter levels over weeks, ketamine rapidly catalyzes structural changes in brain connectivity that can provide relief quickly and potentially create lasting changes in how the brain processes fear and threat.
We offer evidence-based treatment approaches for anxiety, allowing us to tailor your care to your specific needs, medical history, and treatment goals.
Ketamine-Assisted Therapy integrates medication with therapeutic support for a comprehensive treatment experience. This isn’t ketamine administration alone—it’s a structured therapeutic framework that includes preparation, facilitated dosing sessions, and integration work.
Our KAT program offers three delivery methods:
IV Infusion: Intravenous ketamine infusion delivers precise, controlled dosing over 40 minutes. This method provides the most extensively studied approach with predictable pharmacokinetics and the ability to adjust dosing in real-time based on your response.
IM Injection: Intramuscular ketamine injection offers faster onset than IV infusion with high bioavailability. Sessions typically last about two hours, with effects beginning within 5-15 minutes and peak experiences occurring around 30 minutes after administration.
Compounded Nasal Spray: Compounded racemic ketamine nasal spray provides a needle-free option with onset similar to IM administration. This method offers patient-controlled dosing during supervised sessions and may be particularly suitable for those uncomfortable with IV or IM routes.
All KAT sessions, regardless of delivery method, include the same comprehensive therapeutic framework. You’ll work with one of our nine specially-trained facilitators throughout your treatment. Each KAT session includes preparation work to set intentions and address concerns, facilitated dosing in a comfortable private setting with continuous clinical support, and integration sessions to process your experience and apply insights to your healing process.
Ketamine in our KAT program is never administered as standalone medication—the therapeutic components are integral to treatment outcomes. Sessions typically last approximately two hours and occur every 2-3 weeks during the initial treatment series. The combination of medication effects and therapeutic support creates optimal conditions for addressing underlying anxiety patterns and developing new coping mechanisms.
While not a primary treatment for anxiety, NAD+ IV therapy can serve as a complementary wellness approach for some patients. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in cellular energy production and metabolism. Some patients report improved energy, mental clarity, and overall sense of wellbeing with NAD+ therapy, though research on its role specifically for anxiety remains preliminary.
We discuss NAD+ as an adjunctive option for patients seeking additional support for stress resilience, cognitive function, and cellular health during their anxiety treatment. Results vary by individual, and NAD+ therapy should be viewed as complementary rather than a replacement for evidence-based anxiety treatments.
Your treatment journey begins with a comprehensive consultation and screening. During this initial evaluation, we review your psychiatric history, previous medication trials, current symptoms, and overall health. We discuss your treatment goals, answer questions about our treatment approaches, and determine which options may be appropriate for your situation. This screening includes review of medical contraindications and assessment of factors that might affect treatment safety or efficacy.
If ketamine-based treatment is appropriate for your situation, we develop a personalized treatment plan. The typical initial treatment protocol involves six sessions over 2-3 weeks. This initial series allows us to assess your response and adjust dosing as needed. Many patients notice improvements after 2-3 sessions, though the full initial series is recommended for optimal results.
Each KAT session takes place in a private, comfortable treatment room designed to provide a calm, supportive environment. You’ll be in a reclining position throughout the session with continuous clinical monitoring. During the medication phase, you may experience dissociative effects—a sense of detachment from ordinary consciousness, visual or perceptual changes, and altered sense of time or self. These effects are temporary and resolve as the medication is metabolized.
Most patients describe the experience as dreamlike or meditative. Some find it insightful, others simply restful. The dissociative state can provide temporary distance from anxious thoughts and allow exploration of anxiety patterns from a different perspective. Your facilitator remains present throughout, ensuring your safety and comfort. The experience typically lasts 45-90 minutes depending on delivery method and dose, with full return to baseline awareness within 2 hours.
After the initial treatment series, many patients transition to maintenance therapy with sessions spaced 2-6 weeks apart, depending on individual response. Some patients maintain benefits with only occasional booster sessions, while others benefit from more regular maintenance. We work with you to find the maintenance schedule that sustains your improvements.
Results vary by individual. Research suggests that ketamine produces significant anxiolytic effects in controlled studies, with improvements occurring within hours and persisting for days to weeks after administration. Some patients experience dramatic rapid improvement, others notice gradual changes over the initial treatment series, and some have minimal response. The response rates represent meaningful hope for individuals who haven’t found relief with conventional treatments.
Our specialized anxiety treatments may be appropriate if you have generalized anxiety disorder, social anxiety disorder, panic disorder, or specific phobias and have not achieved adequate response from at least two different medication trials at therapeutic doses for adequate duration, often combined with appropriate psychotherapy.
However, ketamine-based treatments are not appropriate for everyone. Medical contraindications include uncontrolled hypertension, history of psychosis or schizophrenia (unless discussing with your psychiatrist), active substance use disorder (particularly with stimulants or alcohol), unstable heart disease, and pregnancy or breastfeeding. We also carefully evaluate patients with certain personality disorders, dissociative disorders, or significant cognitive impairment.
Your comprehensive screening assessment reviews these factors and helps determine whether our treatment approaches are safe and potentially beneficial for your specific situation. If ketamine-based treatment isn’t appropriate, we can discuss alternative treatment options or referrals to other specialists who may be able to help.
At EleMental Health, safety is paramount. All treatments occur under direct medical supervision by qualified practitioners. We maintain continuous monitoring throughout sessions, follow established safety protocols, and have emergency equipment and medications immediately available.
We use evidence-based dosing protocols informed by clinical research and adjust based on individual response and tolerance. Our team stays current with the evolving research on ketamine therapy for anxiety disorders, ensuring our protocols reflect best practices in the field. We coordinate care with your existing mental health providers when appropriate, maintaining continuity in your overall treatment plan.
EleMental Health’s comprehensive approach means you’re not simply receiving medication—you’re receiving care from a multidisciplinary team committed to your safety, comfort, and therapeutic success. Our facilitators bring diverse clinical backgrounds and therapeutic orientations, allowing us to match you with someone whose approach resonates with your needs.
Ketamine-Assisted Therapy for anxiety is offered on a cash-pay basis. Depending on your chosen delivery method and treatment plan, initial consultation plus a 6-session series typically ranges from $2,000-$4,200. Your initial consultation determines the most appropriate option for your situation.
Insurance may cover counseling sessions, medication management, and psychiatric care that occur alongside ketamine therapy. We provide detailed cost information during your consultation so you can make informed decisions about your treatment. For many patients, the rapid relief and potential for sustained improvement justifies the investment, particularly after years of treatment-resistant anxiety.
If you’ve struggled with anxiety that hasn’t responded to traditional treatments, our specialized treatment approaches may offer the relief you’ve been seeking. We invite you to schedule a consultation to learn more about whether these treatment options are right for you.
Call our Boise office or use our online scheduling system to book your initial evaluation. During this consultation, we’ll answer your questions, review your treatment history, and discuss whether our specialized treatment approaches could be an appropriate next step in your anxiety treatment.
EleMental Health is located at 2800 W Overland Rd in Boise, Idaho. We serve patients from Boise and surrounding communities, including Meridian, Nampa, Caldwell, Eagle, Kuna, and beyond. Our accessible location and flexible scheduling make it convenient to integrate anxiety treatment into your life while maintaining your work and personal commitments.
Whether you’re local to Boise or traveling from elsewhere in Idaho, our team is here to provide compassionate, expert care for treatment-resistant anxiety.
The evidence supporting ketamine therapy for treatment-resistant anxiety has grown significantly in recent years. Clinical studies consistently demonstrate rapid anxiolytic effects, with many patients experiencing improvement within hours rather than the weeks required for conventional anti-anxiety medications.
A systematic review and meta-analysis examining ketamine in treatment-resistant anxiety spectrum disorders analyzed six randomized controlled trials including patients with social anxiety disorder, generalized anxiety disorder, post-traumatic stress disorder, and obsessive-compulsive disorder. Results showed significant improvements in anxiety rating scores with ketamine compared to control groups. Improvements in anxiety ratings occurred within one hour of ketamine dosing and persisted for up to one week. The studies demonstrated a dose-response profile, with higher doses producing more substantial anxiolytic effects. Maintenance therapy with ketamine showed sustained anxiety reduction and improvements in social and work functioning.
A comprehensive transdiagnostic meta-analysis specifically examined ketamine’s anxiolytic effects across multiple time points. This analysis included randomized placebo-controlled trials measuring anxiety symptoms in anxiety disorders, depression, chronic pain, and palliative care settings. Results demonstrated that ketamine’s anxiolytic effects emerged rapidly at 3-4 hours post-administration, showed significant improvement at 24 hours, and persisted for up to two weeks after a single dose. The rapid onset and sustained effects represent a significant advantage over traditional anti-anxiety medications.
Research into ketamine’s mechanisms has revealed its effects on neuroplasticity and fear extinction. Studies demonstrate ketamine’s ability to facilitate extinction of avoidance behavior and enhance synaptic plasticity in anxiety-relevant brain circuits. These neuroplastic changes may explain both the rapid symptom relief and the potential for sustained improvements beyond the medication’s presence in the body.
The rapid onset of ketamine’s anxiolytic effects, combined with its ability to help individuals who haven’t responded to multiple conventional treatments, represents a significant advancement in anxiety disorder care. While questions remain about optimal dosing protocols, maintenance strategies, and long-term outcomes, the existing evidence supports ketamine as a valuable option for treatment-resistant anxiety.
Conditions Treated
2800 W Overland Rd, Boise, ID 83705